Multicohort phase II KEYNOTE-059 study of pembrolizumab (MK-3475) for recurrent or metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma

Abstract only

Saved in:
Bibliographic Details
Published inJournal of clinical oncology Vol. 33; no. 15_suppl; p. TPS4135
Main Authors Fuchs, Charles S., Denker, Andrew E., Tabernero, Josep, Van Cutsem, Eric, Ohtsu, Atsushi, Lam, Baohoang, Koshiji, Minori, Bang, Yung-Jue
Format Journal Article
LanguageEnglish
Published 20.05.2015
Online AccessGet full text

Cover

More Information
Summary:Abstract only
ISSN:0732-183X
1527-7755
DOI:10.1200/jco.2015.33.15_suppl.tps4135